comparemela.com
Home
Live Updates
EC approves Novartis Scemblix for chronic myeloid leukemia treatment : comparemela.com
EC approves Novartis' Scemblix for chronic myeloid leukemia treatment
The European Commission (EC) has approved Novartis’ Scemblix (asciminib) to treat chronic myeloid leukemia (CML) in adult patients.
Related Keywords
Norway
,
Iceland
,
Liechtenstein
,
Philadelphia
,
Pennsylvania
,
United States
,
Haseeb Ahmad
,
European Union
,
European Medicines Agency
,
European Commission
,
Committee For Medicinal Products Human Use
,
Europe Innovative Medicines
,
Medicinal Products
,
Human Use
,
comparemela.com © 2020. All Rights Reserved.